Intra-Cellular Therapies Inc. buy Bank of America Co.
Start price
02.01.24
/
50%
€63.50
Target price
02.01.25
€74.81
Performance (%)
-2.36%
Price
19:04
€62.00
Summary
This prediction is currently active. With a performance of -2.36%, the BUY prediction for Intra-Cellular Therapies Inc. by Bank_of_America_Co_ is down slightly. This prediction currently runs until 02.01.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -1.626% | -1.626% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Bank of America Co. from $74.00 to $82.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
18.04.24
18.04.24
€85.29
18.04.25
18.04.25
-12.41%
19:04
19:04
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€58.10
29.03.24
29.03.24
22.14%
30.03.24
30.03.24